Patent details

LUC00007 Product Name: "Eluxadoline ou un énantiomère, un diastéréomère, unracémate ou un sel de celui-ci pharmaceutiquement acceptable"

Basic Information

Publication number:
LUC00007
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP057281719
Legal Status:
Invalid
Application number:
LUC00007
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/16/1126
Marketing Authorization Type:
Marketing Authorization Date:
21/09/2016
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
01/03/2017
First Marketing Authorization date:
21/09/2016
Grant date:
02/05/2017
Activation date:
Publication date:
03/03/2017
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
14/03/2030
SPC Extension Expiration:
14/03/2030
Rejection date:
Withdrawal date:

Owner

From:
01/03/2017
 
 

Name:
Janssen Pharmaceutica NV
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
01/03/2017
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2017/02
Publication date:
22/06/2017
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2017/03
Publication date:
21/07/2017
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
01/03/2017 Application Form 4
03/03/2017 Publication 1
02/05/2017 Certificate 1
01/03/2017 General Document 3
02/05/2017 Publication 1
01/03/2017 General Document 2
01/03/2017 General Document 35